These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37735421)

  • 1. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
    Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
    Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
    Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
    EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.
    Flodrops M; Dujardin G; Busson A; Trouvé P; Ka C; Simon B; Arzur D; Le Jossic-Corcos C; Corcos L
    Mol Biol Rep; 2020 Apr; 47(4):3031-3040. PubMed ID: 32200451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
    Wan L; Yu W; Shen E; Sun W; Liu Y; Kong J; Wu Y; Han F; Zhang L; Yu T; Zhou Y; Xie S; Xu E; Zhang H; Lai M
    Gut; 2019 Jan; 68(1):118-129. PubMed ID: 29114070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
    Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
    J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer.
    Pan YJ; Huo FC; Kang MJ; Liu BW; Wu MD; Pei DS
    Clin Transl Med; 2022 Nov; 12(11):e1113. PubMed ID: 36394206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-read transcriptome sequencing reveals abundant promoter diversity in distinct molecular subtypes of gastric cancer.
    Huang KK; Huang J; Wu JKL; Lee M; Tay ST; Kumar V; Ramnarayanan K; Padmanabhan N; Xu C; Tan ALK; Chan C; Kappei D; Göke J; Tan P
    Genome Biol; 2021 Jan; 22(1):44. PubMed ID: 33482911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.
    Lian H; Wang A; Shen Y; Wang Q; Zhou Z; Zhang R; Li K; Liu C; Jia H
    BMC Gastroenterol; 2020 Jun; 20(1):171. PubMed ID: 32503434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.
    Lin JC; Lee YC; Liang YC; Fann YC; Johnson KR; Lin YJ
    Sci Rep; 2017 Mar; 7():44204. PubMed ID: 28276498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
    Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
    Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised Exon Structure of l-DOPA Decarboxylase (
    Artemaki PI; Papatsirou M; Boti MA; Adamopoulos PG; Christodoulou S; Vassilacopoulou D; Scorilas A; Kontos CK
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
    Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.
    Snezhkina AV; Krasnov GS; Zaretsky AR; Zhavoronkov A; Nyushko KM; Moskalev AA; Karpova IY; Afremova AI; Lipatova AV; Kochetkov DV; Fedorova MS; Volchenko NN; Sadritdinova AF; Melnikova NV; Sidorov DV; Popov AY; Kalinin DV; Kaprin AD; Alekseev BY; Dmitriev AA; Kudryavtseva AV
    BMC Genomics; 2016 Dec; 17(Suppl 14):1011. PubMed ID: 28105922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of single-cell transcriptomics and epigenetic analysis reveals enhancer-controlled TIMP1 as a regulator of ferroptosis in colorectal cancer.
    Li M; Ni QY; Yu SY
    Genes Genomics; 2024 Jan; 46(1):121-133. PubMed ID: 38032469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer.
    Wang C; Weng M; Xia S; Zhang M; Chen C; Tang J; Huang D; Yu H; Sun W; Zhang H; Lai M
    Cancer Sci; 2021 Jan; 112(1):178-193. PubMed ID: 33058325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLASRP oncogene as a novel target for colorectal cancer.
    Gu Q; Wu J; Xu H; Cao H; Zhang J; Jing C; Wang Z; Du M; Ma R; Feng J
    Funct Integr Genomics; 2023 Sep; 23(3):290. PubMed ID: 37658940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
    Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
    Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
    Chang HL; Lin JC
    Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic nanopore long-read sequencing analysis of HIV-1 splicing events during the early steps of infection.
    Nguyen Quang N; Goudey S; Ségéral E; Mohammad A; Lemoine S; Blugeon C; Versapuech M; Paillart JC; Berlioz-Torrent C; Emiliani S; Gallois-Montbrun S
    Retrovirology; 2020 Aug; 17(1):25. PubMed ID: 32807178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel prognostic alternative splicing events in colorectal Cancer: Impact on immune infiltration and therapy response.
    Xiao Y; Gao L; Zhao X; Zhao W; Mai L; Ma C; Han Y; Li X
    Int Immunopharmacol; 2024 Jul; 139():112603. PubMed ID: 39043103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.